





IN CAPE TOWN PRIMARY SCHOOL
CHILDREN
R I Ehrlich, E Jordaan, D du Toit, J A Volmink,
E Weinberg, M Zwarenstein
Background. In view of the high local prevalence of asthma,
the extent of recognition and appropriate management of
childhood asthma was studied in a large suburban area of
Cape Town.
Design. Cross-sectional study based on random community
sample of schools.
Method. 1 955 parents of sub B pupils from 16 schools
completed a questionnaire, followed by: (f) an interview of
the parents of 348 symptomatic children; and (if) bronchial
responsiveness testing on 254 children. 1he final case group
consisted of 242 children with reported asthma or multiple
asthma symptoms on both questionnaires. Children in whom
asthma was acknowledged were compared with those in
whom it was not.
Results. Overall, any past or current (:ever') asthma was
acknowledged by respondents in only 53% of the children,
and current asthma in only 37.1%. While most children had
received treatment in the previous 12 months, 66.1% of the
recognised group were on current treatment (23.2% on daily
treatment), compared with 37% of the unrecognised group
(3% daily). Salbutamol and theophylline syrups were the
most common types of medication, while inhalers and anti-
inflammatory medications were wtderused. Only a minority
of parents reported the child ever having used a peak flow
meter, or volwtteered knowledge of preventive measures.
Current treatment, and to a lesser degree recognition of
asthma by parents, were more common among children on
medical aid and of higher socio-«onomic status.
Coru:lusions. These findings suggest that ways need to be
found: (f) to increase the use of current asthma treatment
guidelines by practitioners; (if) to provide access to
comprehensive care by children not on medical aid; and (iiJ)
to improve education of parents in home management
measures such as severity assessment and avoidance of
smoking, allergen and dietary triggers.
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There is accumulating evidence that childhood asthma is on
the increase in the developed world, reflected in a rise in both
population prevalence and hospitalisation rates in a number of
countries l .' In South Africa asthma appears to be associated
with urbanisation: and it is likely that with its rapid
urbanisation South Africa is also experiencing a rising asthma
prevalence.'
Although asthma is not curable, the quality of life of
asthmatic children can be greatly improved by appropriate
management. Elements of such management include
appropriate anti-inflammatory and bronchodilator medication,
education of caregivers about the disease, home monitoring
and a self-management plan, allergen control, and attention to
psychosocial obstacles to treatment.8.• Guidelines for the
treatment of childhood asthma have been published in South
Africa in recent years l ll-13 However, doubt has been expressed
about the extent of their application in practice."
Appropriate management of childhood asthma requires
acceptance of the diagnosis by parents or caregivers, which in
turn requires recognition by medical practitioners.
Underrecognition and/or undertreatment of childhood and
adolescent asthma have been studied and identified as
problems in the UK,15·16 Australia,17 the Jetherlands'8 and the
USA.'· Differences between socio-economic and ethnic groups
in the recognition and treatment of childhood asthma have also
been noted.'''''' The common finding is that poorer, inner city or
minority status children, depending on the society, tend to
suffer more from their asthma and receive worse care than
better off children.
Cape Town is known to have a relatively high prevalence of
childhood asthma by published international standards,"
which is in turn an important cause of paediatric admission to
hospital.Z2 The aim of the current study was to determine, on
the basis of parental reporting, the degree to which asthma in
young schoolchildren is recognised and appropriately
managed in a large suburban area of Cape Town. The influence
of socio-economic and other factors on the recognition and
treatment of asthma was also examined. The investigation was
population-based to avoid the selection bias in studies of clinic
attenders. This study was part of a larger project examining the
prevalence of asthma symptoms as well as household risk




The study site chosen was a well-defined lower socio-economic
area of Cape Town of approximately 200 000 people, of whom
30000 were aged S - 9 years." A random sample of 16 primary
schools was selected from the 3S in the area. Questionnaires, in
English or Afrikaans, were distributed in July 1993 (winter) via
the children to the parents of all 2 172 sub B pupils (typically
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First sample: 2 172
• .. non-response
1Completed first questionnaire: 1 9551 '
+ .. pilot study, no consent, etc.
2nd sample: 1 736





Met case definition on
both questionnaires: 242
Fig. 1. Sampling pathway to case group.
aged 7 - 8 years) on the class lists of the sample schools. The
questionnaire was based on that currently in use in a
multicountry study of allergic disease in childhood" with the
addition of a question on chest tightness, a term in common
use in this population. The questions are reproduced in
Appendix 1.
The overall prevalence findings have been reported
elsewhere.'! Fig. 1 illustrates how the groups for analysis in this
part of the study were obtained. Questionnaires were returned
by 1 955 parents ( a response rate of 90%). A sampling frame of
1 736 children was obtained, after excluding 83 children from
one school who participated in a pilot study of bronchial
responsiveness testing, 114 who declined consent to be
interviewed, and 22 on whom there was insufficient
questionnaire information. From this second-stage sampling
frame, a preliminary case group of 368 children was defined:
those children with: (i) parent-reported asthma, plus at least
one symptom in the past 12 months (162); or (ii) affirmative
responses to four or more symptom questions referring to the
past 12 months (206). For this purpose frequent wheezing (four
or more occasions) was given the weight of two symptoms.
Interview-administered questionnaire
The parents of the children in the preliminary case group were
visited by bilingual interviewers between 6 weeks and 3
months after the self-completed questionnaires were returned.
These visits took place between September and ovember 1993
(spring to early summer months). In the longer questionnaire
used in the home interview, the asthma symptom questions
used in the first-stage questionnaire were repeated, and further
information was sought on sociodemographic features; the
child's respiratory medical history; history of treatment for
chest symptoms; knowledge of asthma management; and terms
used by the parent and medical practitioner to describe the
child's condition (see Appendix 1). If the child was on current
treatment, the respondent indicated the medication used by the
child with the aid of a chart with photographs of the most
common oral and inhaled medication in local use. The name
and mode of delivery of the medication were recorded by the
interviewer if the information could be obtained.
Bronchial responsiveness (BR) testing
From the preliminary case group of 368 symptomatic children,
a 70% simple random sample was chosen to undergo bronchial
responsiveness testing at school. The sampling was done
because of resource constraints. Absent children were replaced
by the next child on the sampling frame. Histamine challenge
tests were carried out by pulmonary technologists and a
medical prac.?tioner using the long challenge protocol of Yan.2b
A Vitalograph 5-Model dry bellows spirometer was used,
calibrated daily with a 3-litre syringe. Any child judged
clinically by the medical practitioner present to have a
significant respiratory infection on the day was not tested.
Parents were asked, in a letter ent the week before the test, to
withhold routine asthma medication on the morning of the test
unless the child was unwell, but it was not possible to evaluate
compliance with this request.
Each child carried out a standing forced expiratory
manoeuvre without a noseclip until two reproducible tracings,
i.e. within 50 ml of each other, were obtained. The baseline
measurement was repeated after an inhalation of normal saline.
Any child found to have a post-saline forced expiratory volume
in one second (FEY}) of less than 75% of predicted for sex, age
and height was not challenged with histamine. Instead, the
child inhaled two puffs of salbutamol aerosol from a metered
dose inhaler and repeated the expiratory manoeuvre after 10
minutes. A positive bronchodilator test was defined as one in
which the FEV} increased by 15% or more after inhaling
bronchodilator.
In the other children, the test consisted of inhaling doubling
doses of histamine solution delivered with a series of De
Vilbiss 0.40 hand-held nebulisers which dispense an average
of 0.003 ml with each squeeze. The exact amount per squeeze
delivered by each of the nebulisers used in the study was
measured at the beginning of the study and again in the
middle to calculate the delivered dose. The test was ended
when a fall in FEV j of 20% or more from the post-saline value
was recorded (a positive test), or when a cumulative dose of
.. approximately 7.8 J.lIIlol histamine had been reached without
such a fall (a negative test). Any child who experienced a fall of
10% or more in the course of the challenge was given two puffs
of salbutamol at the end of the testing and observed until the
FEV j had returned to its baseline value.
..•
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Table I. Reported symptoms and bronchial responsiveness by
asthma recognition (%) (N =242)
on both questionnaires, so that for 65 of the asthmatic children
bronchial responsiveness status was unknown.
Of the 242 children identified as asthmatic, only 129 (53%)
had recognised asthma (Table I). Even in this group, only 88
(37% of total) were acknowledged as 'still' having asthma
(Appendix 1, question 13.1). Even on the stricter criterion for
case status of persistent symptoms plus bronchial
responsiveness (100 children), recognition of asthma occurred
in only 62%, of whom 45% were acknowledged as current.
The unrecognised group had significantly higher prevalences
of wheeze, sleep disturbance and night cough than the
recognised group (Table I). By contrast a higher proportion of
the recognised asthma group had a positive bronchial
responsiveness test (62% v. 41%; P = 0.07).
The mother was identified as the respondent in 85% of both
the recognised and unrecognised asthma group. The majority
of children were aged 6 - 8 years. Boys made tip just over half
of both groups.
Table IT describes the terms offered by the respondent to
describe the child's respiratory problem, as well as the terms
attributed to the child's doctor (see Appendix I). The term
asthma was offered by only 31.0% of the recognised group and
2.7% of the unrecognised group (the latter thus contradicting
the response to the direct question about asthma). The largest
proportion in both groups preferred 'tight chest' ('toebors').
Wheeze/wheezing chest was rarely used. In describing what
term the doctor used, 'asthma' was reported by the majority
(71.9%) of the recognised group. In the unrecognised group,
'bronchitis' (20%) and 'cold' ('verkoue op die bars') were the
majority responses.
Almost all of the children in both groups had received some
treatment for asthma symptoms in the previous 12 months
(Table Ill). However, while 23.2% of the recognised group were
on daily treatment, and a further 42.9% on treatment as
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Symptom proportions in the two groups as well as the
proportions of the two groups reporting various aspects of
management and knowledge of asthma were compared using
the likelihood ratio chi-squared statistic. The associations of
sociodemographic, medical and family history factors and
symptom severity with asthma recognition, current treatment
and use of an inhaler were tested in bivariate analyses. In this
cross-sectional design, the measure of effect presented in Table
V is the prevalence ratio. The Cox proportional hazards model
was used to obtain the point estimates and the corresponding
95% confidence intervals.
Of the 368 interviews planned, 20 were not conduded either
because the child did not live in the study area or because
access was not obtained. A total of 348 home interviews were
successfully conduded, a response rate of 94.5%. A total of 243
children qualified as asthmatic by meeting the criteria for case
status on both the initial and repeat questionnaires, and full
information was available for 242 (Fig. 1).
A total of 254 children successfully underwent bronchial
responsiveness testing, 244 of these completing the histamine
challenge test and 10 the bronchodilator test. Of another 42
children invited to the testing, 14 were absent on the day, 14
were judged to have a Significant respiratory tract infection, 7
were unable to perform an adequate test, and 5 were no longer
at the school; in 2 cases the test was curtailed because of time.
Of the group that underwent bronchial responsiveness testing,
however, only 178 children also met the criteria for case status
Definition of asthma and appropriateness of
treatment
For purposes of evaluating recognition and treatment, those
children who met the criteria for case status (see above) on
both the self-administered and interview questionnaires were
regarded as having asthma. They were further subdivided into
those children for whom the respondent answered yes to the
question 'has your child ever had asthma' on the second
(interview) questionnaire, and those for whom the respondent
answered no. Current treatment was defined as affirmative
response to the question 'is your child currently on treatment
from a doctor for any of the following symptoms:
wheezing/whistling in the chest, tight chest, night cough or
asthma?' Appropriateness of treatment was inferred by
comparing reported treatment against the recommended South
African guideline published in 1992.10
The study was approved by the Ethics and Research
Committee.of the University of Cape Town Medical Faculty,
and informed consent for study participation and histamine
testing was obtained from the parents of all participating
children.




Table II. Tenns to describe child's chest symptoms* used by
respondent or attributed to doctor, according to astluna
recognition (N = 242)
ame used by respondent




Sore chest 5.4 12.4
Short breath 2.3 2.7
Wheezing chest 5.4 4.4
Other 5.4 9.7
one 10.1 8.0




Tight chest 3.5 9.0
Other 4.4 7.0
one 6.1 8.0
,. See appendix, questions 7 and 8.1.
treatment, with a large proportion (63%) on no current
treatment. Children in the recognised group were more likely
to have been treated privately and/or at Red Cross War
Memorial Children's Hospital. By contrast, the day hospital
was a more common site of treatment of children in the
umecognised group.
With regard to types of medication currently used, syrups
were mentioned by a large majority of the respondents to this
question (90.5% and .9% in the recognised and umecognised
group, respectively), with pills the next most common mode of
treatment reported. Inhalers were used by 44.6% of the
recognised group and only .30~ of the umecognised group.
Nebulisers were as commonly used as inhalers (the question
did not distinguish beh-veen nebuliser use in a clinic or surgery
and at home). Only 46.8% of the recognised group and 13.2% of
the umecognised group reported that the child had ever used a
peak flow meter.
Response rates to the questions about home preventive
measures were low (Table Ill). Of the IH who answered the
question about preventive bedroom measures, a minority
(16.4% in the recognised asthma group, 8.7% in the
unrecognised group) mentioned avoidance of smoking in the
child's bedroom. Even fewer respondents (60) answered the
question about dietary avoidance. Among these, the most
common reference was to cooldrinks. There ",'ere no significant
differences beh'Veen the h'Vo groups in these responses.
A total of 101 of the 242 respondents provided more detail
about the treatment the child used currently, either daily or as
needed (Appendix I, question 9.1). Based on these responses,
Table ill. Treatment and parental knowledge of home

































































Peak flow meter (ever used) (N = 242)

















• 0.005 < P < 0.01 for difference
• p < 0.005 for difference.
, p < O.jJ(J()l for trend.
,. See appendix, questions 10 and 11.
'freatment in past 12 months
(yes = 215)






Current treatment (N = 215)
Everyday
As needed
the number of times a specific medication/mode of delivery
was mentioned is listed in Table IV. Salbutamol was most
commonly mentioned, with a syrup preparation the most
frequent mode of administration. Other beta-2-agonists,
including fenoterol, were mentioned much le commonly. The
next most popular medication was the theophyllines, again
with syrups the most common form. Anti-inflammatory
medication was identified relatively few times: inhaled
corticosteroids 9 times, oral corticosteroids 11, and sodium
cromoglycate 12. The remainder of the medications mentioned









• refers tonumberof respondents who gave information. As a single respondent
could menb.on multiple medications, numbers in table do not refer to respondents.




























positive in both questionnaires, the prevalence of asthma
(current or past 12 months) is 242/1 736, i.e. approximately
14%. If one adds the requirement of a positive bronchial
respoffiiveness test and adjusts for the subsampling done for
bronchial respoffiiveness testing, the prevalence of current (and
presumably more severe) asthma is 7.8%. These point estimates
would be closer to 13% and 7% if one assumes that non-
respondents to the first questionnaire had children with fewer
symptoms. These figures are higher than the 5% sometimes
cited as the urban prevalence of asthma in South Africa. A
reasonable approximation of the prevalence of clinically
significant asthma in Cape Town is therefore between 7% and
13%, depending on definition of severity. If mild or occasional
asthma is included, the prevalence based on reports of recent
wheezing, tight chest, and exercise wheeze in this population
may be as high as 25%."
The results of this study show that asthma, a common disease,
is underrecognised and undertreated in this population of
Cape Town schoolchildren. There are certain limitations in a
study of this nature. Diagnosis of asthma and assessment of its
severity are clinical processes; epidemiological definitions can
make only approximate classifications. Epidemiological studies
may, for example, identify infrequently symptomatic children
who would not merit diagnosis or treatment because of the
mildness of their condition.
For these reasons, a relatively strict epidemiological
definition was used in an attempt to make the group as specific
to clinical asthma as possible. To qualify, respondents had to
acknowledge multiple symptoms typical of asthma and/or a
diagnosis of asthma on both of two questionnaires 3 - 4 months
apart. A positive bronchial responsiveness test was not used to
define asthma, as it is relatively insensitive in detecting asthma
in population studies.""'" In this study it can be regarded as a
marker of severity of asthma and of current activity of the
child's asthma.
The first finding was that only about half of the respondents
for these symptomatic children acknowledged any asthma
history, while only a third acknowledged current asthma.
Recognition should (approximately) be a function of severity.
Surprisingly, while the recognised asthma group had a higher
proportion of children with positive bronchial responsiveness
tests, symptom prevalences were equivalent or higher in the
unrecognised group. This may reflect a treatment effect, with
the asthma in the recognised group being better controlled.
Labelling of ill-health is a complex phenomenon, reflecting
medical practice, parental education, parental willingness to
accept the diagnosis or the management of the problem, and
explanatory constructs held by parents of cause and natural
history.'" Practitioners may use less specific diagnoses or be
reluctant to use the term asthma for fear of alarming parents.
o. SAMJ
Variables examined in relation to asthma recognition, current
treatment and inhaler use were demographic (age, sex);
medical history (hayfever, eczema, parental asthma); socio-
economic (school, household crowding, number of other
children in the household, maternal and paternal education
and employment status); health care (medical aid, use of
private doctor or day hospital); and severity (frequent wheeze,
speech disturbance, positive bronchial responsiveness).
Covariates reaching statistical significance in any association,
plus those of a priori interest, are presented in Table V. Older
children, and those with hayfever or a parental history of
asthma, were more likely to be in the recognised asthma group.
Having medical aid and attending a private doctor were also
associated with recognition, while day-hospital attendance was
associated with non-recognition.
Similar factors were associated with being on current
treatment, with the addition of eczema and some socio-
economic variables (higher socio-economic status school, and 3
or fewer other children in the household). A positive bronchial
responsiveness test was also significantly associated with
current treatment. The only predictors of inhaler use (among
the group of 112 children on current treatment) were hayfever
and 3 or fewer other children in the household.
Finally, it is of interest to estimate the population prevalence
of asthma from this study. Based on the definition of case
August 199 , Vo!.
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Table V. Predictors of asthma recognition, current treatment and inhaler use in asthmatic primary school children
Asthma recognition (N = 242) Current treatment (N =242) Inhaler use (N =112)
Prevalence Prevalence % Prevalence
% ratio (95% Cl) % ratio (95% Cl) % ratio (95% Cl)
Age (yrs)
6-7 62.3 1.3 (1.03 - 1.66) 50.9 1.13 (0.86 - 1.48) 33.9 1.08 (0.63 - 1.87)
8 -11 47.8 45.1 31.4
Hayfever
Yes 62.1 129 (1.02 - 1.62) 67.4 1.93 (1.48 - 2.51) 40.3 1.83 (1.00 - 3.35)
No 48.3 34.9 22.0
Eczema
Yes 60.3 1.19 (0.94 - 1.52) 59.4 1.41 (1.09 - 1.84) 36.6 124 (0.72 - 2.12)
No 50.6 42.1 29.6
Parental asthma
Yes 47.7 1.45 (1.16 - 1.81) 49.7 1.15 (0.84 - 1.57) 31.3 0.91 (0.50 - 1.65)
No ~9.1 43 n 34.5•.:>
Medical aid
Yes 65.5 1.4 (1.11 - 1.76) 56.1 1.35 (1.03 - 1.76) 30.4 0.89 (0.51 - 1.54)
No 46.8 41.7 34.9
Treated by private doctor
Yes 60.2 1.45 (1.09 - 1.92) 58.6 1.39 (1.05 - 1.85) 29.3 0.75 (0.44 - 1.29)
No 41.6 42.1 38.9
Treated at day hospital
Yes 40.0 0.67 (0.49 - 0.90) 38.8 0.65 (0.48 - 0.89) 30.0 0.90 (0.48 - 1.69)
0 59.9 59.6 33.3
Socio-economic
status of school
High 57.9 1.23 (0.96 - 1.58) 53.3 1.37 (1.03 - 1.83) 32.4 0.98 (0.56 - 1.72)
Low 47.1 38.8 32.5
Other children
in household
:53 56.8 123 (0.94 - 1.61) 52.2 1.42 (1.03 - 1.97) 37.4 2.17 (0.93 - 5.04)
>3 46.3 36.7 172
Bronchial
responsiveness test
+ 62.6 129 (0.98 - 1.69) 58.2 1.97 (1.35 - 2.89) 33.3 1.53 (0.65 - 3.62)
48.7 29.5 21.7
o ; confidence interval.
Bronchitis, and to a lesser extent 'verkaue ap die bars', were the
terms other than asthma most commonly attributed to medical
practitioners by parents in both groups, reflecting belief in an
infective cause of the symptoms. Alternatively, even if asthma
is diagnosed by the practitioner, he or she may not convey the
implications of the diagnosis to the parents effectively, or
parents may be reluctant to accept the diagnosis or the
chronicity of the condition. Fear of the prognosis or guilt over
perceived neglect of the child may underlie this reluctance.
When asked what terms they used to describe the child's chest
symptoms, the majority of parents who had acknowledged
asthma in a direct question offered 'tight chest' and a variety of
other terms rather than asthma.
The importance of diagnosis rests on the hypothesis that
specific asthma management is more likely to follow if the
correct diagnosis is made. This study lends support to this
hypothesis in that children with recognised asthma were
considerably more likely to be on current treatment, and
especially on daily treatment, than if asthma was not
acknowledged.
The existence of a published guideline based on a graduated
approach to treatment allows for evaluati.on of the
manc.gement items reported by respondents. Although the
latest guidelineIl postdates the study, earlier guidelines have
been published. lo While approximately 90% of all symptomatic
children had received some form of treatment in the last 12
months, this did not appear to conform to the recommended
protocol. Although the protocol re~ommendedbeta-2-agonists
as first-line therapy rather than theophyllines, a sizable
proportion of children on whom specific information was
provided were on a theophylline preparation. In addition,
inhaler therapy was used by less than half of the children in the
recognised group, and less than 10% in the unrecognised
group. The overwhelming majority of children were on some
••
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form of oral medication, particularly syrups. This preference
for oral treatment may be because of a fear of inhaler therapy
(e.g. a perception that it is addictive or weakens the heart"') or a
preference for compound linctuses or syrups offering 'broad-
spectrum' symptomatic treatment, or because oral medication
appears cheaper. Later guidelines have emphasised that
inhaled therapy is preferable to oral therapy. Use of syrups, in
particular, may make it difficult to achieve the correct dose.
In the 1991 guideline,!o bronchodilator therapy was
recommended only whenever necessary (pm medication), with
the addition of maintenance inhaled cromoglycate for
moderate asthma and steroids for severe asthma. In the
recognised asthma group, 23% were on daily medication.
While this would include a proportion appropriately on anti-
inflammatory treatment such as cromoglycate or steroids,
given the medications cited in Table IV and the underuse of
inhalers, it is likely that a sizable proportion of this daily
therapy was bronchodilator medication. Similarly, it can be
inferred that anti-inflammatory treatment was uncommon in
the unrecognised group. Underuse of anti-inflammatory
medication has been associated elsewhere with increased
morbidity31 and may be one of the factors contributing to high
asthma morbidity" in this population.
A majority of children overall (59.1%) received some of their
treatment from a private general practitioner, despite the facts
that only 34.9% came from families on some form of medical
aid, and that a high proportion were of lower socio-economic
status as reflected in education and household variables. A
substantial fraction (43%) in the recognised group and 22% in
the unrecognised group had been treated at some time at Red
Cross Hospital. This accords with other findings that even in
low-income areas patients may use some combination of
private practitioners and State hospitals in preference to day
hospitalsY Treatment at the hospital may reflect greater
severity of asthma and appropriate referral, but may also
include inappropriate use of the hospital for primary care. I '
Although the management of asthma should include the use
of a peak flow meter in diagnosis, assessment and monitoring
of airways obstruction, only about half the recognised group of
respondents and 13.2% of the unrecognised group could recall
the child ever using a peak flow meter, even with a
photographic prompt. With regard to home use, however, these
meters are relatively expensive (price range as of mid-199B
approximately R90 - > R200) and are not reimbursable by all
medical aid schemes.
The home and bedroom environment merits attention in
managing asthma because of the importance of house dust
miteD and environmental tobacco smoke'" in causing and
maintaining asthma symptoms in this population. Diet is
another important area of management in some cases because
of the role of sulphited drinks and foodstuffs in triggering
asthma in susceptible children." The lack of any significant
difference between the two groups in their responses on the
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open-ended questions about preventive measures may partly
be due to the low response rate to these questions, but may
also reflect a low priority given by medical practitioners to
these measures, even in diagnosed children.
In examining potential barriers to recognition and treatment,
we found that the absence of medical aid was a strong
predictor of non-recognition and non-treatment. Medical aid is
a marker of both socio-economic status and, independently, of
access to medical care. Apart from medical aid, current
treatment and inhaler use were less likely in children with
some but not all indicators of lower socio-economic class.
Overall, this seems to confirm the association of poor asthma
control with lower income status. American studies have
suggested that children from lower income homes are more
likely to use multiple carers and make heavier reliance on
hospital emergency facilities, resulting in fragmented care and
absence of asthma management plans.".20 Children from poorer
areas may also be less likely to be on anti-inflammatory
medication, contributing to greater morbidity and
hospitalisation." Similar factors are likely to operate in this
population.
Amid many pressing problems in child health in South
Africa, asthma was not recognised as a priority in a recent
policy doclLrnent on child health.35 It is arguable whether
enough is known at this stage to develop policies on primary
prevention of asthma.30.37 However, sufficient is known about
secondary prevention to develop a primary care asthma
strategy. Such a strategy might include 24-hour medical care in
proximity to where people live to encourage adequate
utilisation of primary care services. It would also include
promotion of the use of consensus guidelines by health
professionals. In this respect, acceptability of guidelines to
primary care practitioners may be influenced by the extent to
which they have been involved in their development. There is
also a role for asthma education at schools focused on
improved recognition of asthma by staff, encouragement of
participation in sport by asthmatic children, the management
of acute attacks and provision of support for parents.30
A start to a national strategy has been made with the
National Asthma Education Programme.39 However, cost of
medication has to be recognised as a barrier to effective asthma
care in South Africa. A local cost-effectiveness analysis of
asthma management would therefore be useful for assessing
the likelihood of achieving compliance with recommended
management protocols in low-income communities. Also, while
there is evidence from elsewhere that targeted house dust
avoidance measures can reduce symptoms in asthmatic
children, the effectiveness of these measures on a large scale
has yet to be confirmed in this population."
Finally, an asthma strategy should also add force to activities
aimed at reducing maternal and household smoking and
fighting the penetration of tobacco marketing into poor
communities.42
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ApPE DIX I. QUESTIO S USED I SELF-
ADMI ISTERED AND/OR INTERVIEW
QUESTION AIRE AS BASIS OF CASE
DEFINITION
1. Has your child had wheezing or whistling in the chest in the
last 12 months?
1.1 How many attacks of wheezing or whistling in the
chest has your child had in the last 12 months?
2. In the last 12 months how often, on average, has your
child woken up due to chest wheezing or whistling? (every
week / not every week / never)
3. In the last 12 months, has wheezing or whistling in the
chest ever been so bad that your child couldn't talk properly
or had to whisper?
4. In the last 12 months, has your child's chest ever sounded
'vheezy or whistly, during or after running or playing hard?
5. In the last 12 months has the child had a troublesome dry
cough in the night that was not from a cold or chest
infection?
6. In the last 12 months, has the child had a tight chest?
7.* In talking about these symptoms (wheeze, tight chest,
night cough) with your doctor, family or friends, what
name do you use to describe the problem? (record)
8.. During the past 12 months, has the child received any
treatment from a doctor for any of the following
symptoms? (wheezing/whistling in the chest, tight chest,
difficulty sleeping because of cough)
• •
ORIGINAL ARTICLES
8.1* What name(s) did the doctor use to describe the
child's chest problem? (record)
8.2* Where did the child go for treatment for this chest
problem? (private doctor, day hospital, Red Cross
Hospital, other hospital or clinic, other (specify»
9*. Is the child currently on any treatment for any of the
following: wheezing/whistling in the chest, tight chest,
night cough or asthma?
9.1* If yes what treatment? (tablets, syrup, inhaler,
nebuliser (oxygen), injection, other (specify»
10.* Do you know of anything you can do inside the child's
bedroom to prevent allergy or breathing problems? (record)
11.* Do you know of anything your child can avoid eating or
drinking so as to prevent allergy or breathing problems?
(record)
12.* Has the child ever been asked by a doctor or nurse to
blow into a peak flow meter? (show picture of meter)
13.* Has the child ever had asthma?
13.1* Does s/he still have asthma?
• Interview (2nd) questionnaire only.
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LUNG FUNCTION IN SOUTH
AFRICAN CHILDREN WITH CYSTIC
FIBROSIS
H J Zar, B Moore, A Argent, J Ireland, A T R Westwood
Objediue. To determine the pattern of lung function in stable
cystic fibrosis (CF) patients and to investigate the relatiooship
of abnormal hmg function to demographic variables, CF
genotype and puImoIIary colonisation with PseudomtnrIls
~(pA).
Design. A descriptive study done at the CF ctinic at Red Cross
War Memorial QWdren's Hospital in Cape Town.
Methods. Datawere recorded and pulmonary function testing
(PFI) was perfomled in 42 CF patients.
RtsulIs. 29 patients (69%) had mild diseiIse,. while 11 (26%)
and 2 (5%) had moderate and severe disease~
Twenty-four patients (57'%) demoltstridled lower airway
obstuKDoo (LAO). Patients with moderate or severe disease
were significantly older than those with mild disease (133
(3.7) years (mean (SD» oompared with 11.1 (3.0) years
(t =2.1; P =OM». PA mIonisation status ctiffer'ed
significantly with the patIIem of lung function <r =6.6; P =
0.04) and severity of lung disease <r =12.6; P =0.002.). Nine
(35%) of the 26 patients tesIed before and afterbroncbodilator
therapy showed a positive n:spoose.
ConcbIsiorL The majority of patients had mildly impaired or
normal lung fuDction. withLAD predominating. A minority
of patients were bmncbodilatoMesponsive. PA colonisation
may be associated with the deveIopmeut of abnormal lung
function and DKlIe severe pnJmmary disease..
sAIrIIIIi'llJ1lll; .9M-991.
Cystic fibrosis (CF) is one of the most common serious
inherited disorders among South Africa's white and coloured
populations' and may be more common than formerly realised
in the black population! Clinical manifestations include
pancreatic insufficiency, hepatic dysfunction, infertility and
pulmonary disease. Of these, pulmonary disease, characterised
by endobronchial bacterial infection and neutrophil-dominated
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